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BupivacaineAbstract Background: This is a prospective randomized double blind study to compare the
efﬁcacy of intravenous amino acid infusion versus meperidine added to intrathecal hyperbaric
bupivacaine in reducing intraoperative shivering in parturient undergoing elective cesarean section
under spinal anesthesia.
Methods: Sixty patients were randomly allocated into two groups. Group (A) (Amino-acid)
(n= 30) who received 2 ml of 0.5% hyperbaric bupivacaine and ½ ml normal saline 0.9% (total
volume 2.5 ml) intrathecal with intravenous administration of amino acids (Aminoven 5%,
Fresenius Kabi), infused at rate 3 ml/kg/h with the start of spinal anesthesia and throughout the
operation. Group (M) (meperidine) (n= 30) who received 2 ml of 0.5% hyperbaric bupivacaine
with 10 mg meperidine in ½ ml volume (total volume 2.5 ml) intrathecal with intravenous
administration of normal saline 0.9% at 3 ml/kg/h with the start of spinal anesthesia.
Results: Group (A) showed signiﬁcantly higher core temperature from 20 to 60 min than group
(M) (p< 0.001), also the amino acid group (group A) had a signiﬁcantly higher skin temperature
from 10 to 60 min during surgery, and lower shivering score than group (M) (p< 0.05), during
spinal anesthesia in parturients undergoing cesarean section.
Conclusion: Amino acids infusion decreased the incidence of shivering, increased peripheral and
core temperature than intrathecal meperidine, which seems a safer alternative, more effective with
lesser side effects than intrathecal meperidine in parturients undergoing cesarean section under
spinal anesthesia.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).t, Cairo,
oo.com
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Shiveringmay occur as an adverse effect of surgery and anesthe-
sia. Shivering associated with spinal anesthesia is a frequent
event, and the reported median incidence of shivering related
to neuraxial anesthesia is up to 55% [1]. The mechanism of
shivering in patients undergoing spinal anesthesia is not clear
but hypothermia due to redistribution of heat caused by vasodi-
lation below the level of a neuraxial block is suggested. Spinal
anesthesia also impairs the thermoregulation system by inhibit-
ing vasoconstriction. Shivering increases oxygen consumption,
metabolic rate, lactic acidosis, carbon dioxide production,
plasma catecholamines and cardiac output. Shivering move-
ment may interfere with monitoring of hemodynamics as well
as increasing patient discomfort and distress. Therefore, it is
very important to prevent shivering during spinal anesthesia
[2]. Core temperature is maintained within normal limits of
36.5, 37.5 C [3], even in the presence of an adverse environmen-
tal temperature, by a combination of behavioral and physiolog-
ical responses. Anesthesia abolishes behavioralmechanisms and
has the potential to disrupt the physiological mechanisms of
thermoregulation. Intraoperative core temperature depends
both on distribution of heat within the body and on systemic
heat balance. During the ﬁrst four hours of anesthesia, core-
to-peripheral redistribution of heat is the primary cause of core
hypothermia [4]. Hypothermia results from heat loss exceeding
heat production [5] as anesthetics profoundly impair thermoreg-
ulatory control [6,7]. Factors that increase thermogenesis or
reduce loss of heat to the environment moderate the rate at
which intraoperative hypothermia develops [8–10].
Enteral or parenteral administration of amino acid solution
stimulates oxidative metabolism, typically increasing
metabolic rate by 20% [11,12]. Thermo-genesis associated with
amino acid infusions has been shown in numerous studies to
help preserve intraoperative core temperature [8,13] and to
moderate complications associated with hypothermia [14–16].
Meperidine possesses special antishivering properties that
are not shared by pure l-receptor opioids. There are many
studies for meperidine via intravenous, Intrathecal, and epidu-
ral administrations [17]. Possible suggested mechanisms for the
antishivering effect of meperidine include j-opioid receptor
activity, anticholinergic action, biogenic monoamine reuptake
inhibition, NMDA receptor antagonism or stimulation of
a-adrenoceptors [18–21].
This prospective, randomized, double blind study was
performed to compare the antishivering effects of intravenous
administered amino acid solution versus meperidine added to
intrathecal hyperbaric bupivacaine in patients who underwent
elective cesarean delivery under spinal anesthesia.
2. Patients and methods
After receiving approval from the ethics committee at obstet-
rics and gynecology teaching hospital of Ain Shams University
and informed written consent from patients, 60 patients (ASA
physical status I or II) scheduled for elective cesarean delivery
under spinal anesthesia, were enrolled in the study. Patients
with contraindications to regional anesthesia, allergy to the
study medications, obesity (Body Mass Index (BMI)
= 30 kg/m2, class I and above), preeclampsia, placenta previa
or diabetes were excluded.Patients were divided into two groups by using computer
generated random tables with closed sealed envelopes. An assis-
tant who was not involved in the study prepared the medication
before giving spinal anesthesia. Heart rate, blood pressure and
oxygen saturation monitoring were established. Patients were
given intravenous Ringer’s solution. Oxygen 3 liters per minute
(3 LPM) was administered through nasal prongs during
anesthesia. Spinal anesthesia in the sitting position at the L3–4
interspace with a midline approach uses 25 G or 27 G Quincke
needle. In groupA (Amino-acid group, n= 30), Spinal anesthe-
sia consisted of 2 ml of 0.5% hyperbaric bupivacaine +½ml.
of normal saline 0.9%, total volume 2½ ml, together with intra-
venous administration of Aminoven 5%, Fresenius Kabi, (that
can be given in a peripheral venous access) at a rate of 3 ml/kg/h,
while, Group M (meperidine group n= 30), received 2 ml of
0.5% hyperbaric bupivacaine, plus 10 mg pethidine in ½ ml
volume, total volume 2½ ml. intrathecal, together with intra-
venous administration of normal saline 0.9% at a rate of 3 ml/
kg/h. After giving spinal anesthesia, patients were positioned
supine with a wedge beneath the right hip to maintain a pelvic tilt
of 30. Sensory levels were determined by pinprick and the motor
blockage was evaluated using Bromage’s criteria. Core tempera-
ture was measured from the rectum where the rectal probe was
inserted during urinary bladder catheterization of the patient
and skin temperature was taken from the forehead before
establishing regional anesthesia as baseline and at 10 min interval.
Shivering was recorded during surgery and in the recovery room
by a blind observer. Shivering was graded on a scale:
 0 = no shivering.
 1 = piloerection or peripheral vasoconstriction but no visi-
ble shivering.
 2 = muscular activity in only one muscle group.
 3 = muscular activity in more than one muscle group but
not generalized shivering.
 4 = shivering involving the whole body [22].
The operating room temperature was maintained at
23–25 C, and perioperative side effects including pruritus,
sedation, nausea and vomiting were recorded.
3. Statistical analysis
Analysis of datawas done by using SPSS (statistical program for
social science version 16) where, quantitative variables were
expressed as mean, SD and range, while qualitative variables
as number and percentage. Chi-square test was used to compare
qualitative variables between groups, whereas, unpaired t-test
was used to compare two independent groups as regards quan-
titative variable.P value > 0.05was considered non-signiﬁcant,
P< 0.05 signiﬁcant, and P< 0.001 highly signiﬁcant.
Reference
M. Clinton Miller, Rebecca G. Knapp (1992): Clinical
epidemiology and biostatistics, published by Williams &
Wilkins, Maryland: 3rd edition.
4. Results
The study was conducted from May 2014 to February 2015; 60
women participated in the study and all completed the study.
Demographic variables were similar in both groups,
(p> 0.05) (Table 1).
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from 20 to 60 min than group (M) (p< 0.001) (Table 2).
Also the amino acid group (group A) had a signiﬁcantly
higher skin temperature from 10 to 60 min during surgery,
and lower shivering score than group (M), during spinal anes-
thesia in parturients undergoing cesarean section (p< 0.05)
(Tables 3 and 4).
The incidence of side-effects in the form of nausea and
vomiting, sedation and pruritus was not statistically signiﬁcant
among both groups (p> 0.05) (Table 5). As well, there were
no statistically signiﬁcant differences between the two groups
as regards the neonatal outcomes (p> 0.05) (Table 6).
5. Discussion
Spinal anesthesia decreases the vasoconstriction and shivering
thresholds to a certain degree [23] because local anesthetics
have no thermoregulatory effects [24]. The mechanism of thisTable 1 Comparison between both groups as regards demographic
Variables Group A
(n= 30)
Age (years) 30.4 (4.1)
Weight (kg) 72.8 (6.1)
Height (cm) 158.4 (5.3)
Gestational age (weeks) 38.8 (1.1)
Surgery time (min) 62.4 (7.2)
Ambient OR temperature (C) 23.9 (0.87)
Data were expressed as mean (SD), P> 0.05 non-signiﬁcant.
Table 2 Comparison between both groups as regards core tempera
Time after spinal anesthesia Group A
(n= 30)
0 36.4 ± 4.1
10 min 36.2 ± 5.3
20 min 35.9 ± 7.1 "
30 min 35.5 ± 6.2 "
40 min 35.2 ± 3.1 "
50 min 35.3 ± 4.2 "
60 min 35.0 ± 3.1 "
Data were expressed as mean ± SD, P> 0.05 is non-signiﬁcant, P< 0.
Table 3 Comparison between both groups as regards skin tempera
Time after spinal anesthesia Group A
(n= 30)
0 35.5 ± 2.1
10 min 35.2 ± 3.1 "
20 min 35.0 ± 8.1 "
30 min 34.8 ± 5.1 "
40 min 34.5 ± 6.2 "
50 min 34.2 ± 5.3 "
60 min 33.9 ± 1.2 "
Data were expressed as mean ± SD, P> 0.05 is non-signiﬁcant, P< 0.disturbance during regional anesthesia is unknown but is con-
sistent with thermoregulatory impairment caused by the effects
of the regional block upon afferent thermal information.
Hypothermia is associated with shivering and excessive
sympathetic nervous system stimulation [25], metabolic acido-
sis, platelet activity is impaired [26] and there is prolongation
of the coagulation time and decreased clot formation rate
[27,28]. Impaired immune function and delayed wound healing
have been demonstrated [29,30].
In our study we compared intravenous amino-acid infusion
– Aminoven 5% – to intrathecal meperidine, as regards efﬁ-
cacy in aborting or reducing shivering in parturient undergoing
cesarean section under spinal anesthesia. It was found that
intravenous amino acid infusion during spinal anesthesia ele-
vates core and skin temperature and decreases shivering rate
more than intrathecal meperidine administration, which seems
a safer alternative, more effective and lesser side effects than
intrathecal meperidine; yet, further studies are recommendeddata.
Group M
(n= 30)
P-value
30.8 (3.2) (0.89) NS
78.2 (4.7) (0.35) NS
160.1 (3.2) (0.66) NS
39.0 (1.2) (0.70) NS
60.2 (8.1) (0.40) NS
24.3 (1.1) (0. 123) NS
ture.
Group M
(n= 30)
P-value
36.9 ± 5.1 (0.83) NS
35.8 ± 7.2 (0.70) NS
35.2 ± 4.2 (0.04) S
34.9 ± 5.1 (0.02) S
34.5 ± 2.8 (0.002) S
34.4 ± 3.6 (0.001) S
34.2 ± 1.5 (0.01) S
05 signiﬁcant, while P< 0.001 is highly signiﬁcant.
ture.
Group M
(n= 30)
P-value
35.2 ± 4.1 (0.78) NS
34.8 ± 7.2 (0.05) S
34.7 ± 6.1 (0.04) S
34.2 ± 3.2 (0.04) S
33.8 ± 4.1 (0.002) S
33.5 ± 6.2 (0.01) S
33.2 ± 3.1 (0.02) S
05 signiﬁcant, while P< 0.001 is highly signiﬁcant.
Table 4 Comparison between both groups as regards shivering score.
Time passed after spinal anesthesia Group A
(n= 30)
Group M
(n= 30)
X2 P-value
0 0 0 – –
10 min 0 0 – –
20 min 5.3 (0.02) S
0 20(66.7%) 17(56.7%)
1 4(13.3%) 5(16.7%)
2 6(20%) 8(26.7%)
30 min 5.7 (0.001) S
0 15(50%) 10(33.3%)
1 5(16.7%) 9(30%)
2 5(16.7%) 6(20%)
3 5(16.7%) 5(16.7%)
40 min 4.3 (0.04) S
0 12(40%) 8(26.7%)
1 6(20%) 7(23.3%)
2 6(20%) 10(33.3%)
3 6(20%) 5(16.7%)
50 min 4 (0.05) S
0 10(33.3%) 8(26.7%)
1 9(30%) 7(23.3%)
2 6(20%) 10(33.3%)
3 5(16.7%) 5(16.7%)
60 min 3.7 (0.05) S
0 8(26.7%) 8(26.7%)
1 10(33.3%) 7(23.3%)
2 7(23.3%) 12(40%)
3 5(16.7%) 3(10%)
In the recovery room 6.8 (0.002) S
0 5(16.7%) 2(6.7%)
1 10(33.3%) 8(26.7%)
2 8(26.7%) 11(36.7%)
3 6(20%) 6(20%)
4 1(3.3%) 3(10%)
Data were expressed as number percent.
P> 0.05 is non-signiﬁcant, P< 0.05 signiﬁcant, while P< 0.001 is highly signiﬁcant.
Table 5 Incidence of maternal adverse reactions in the ﬁrst
24 h post-operatively.
Side-eﬀect Group A
(n= 30)
Group M
(n= 30)
P-value
Nausea and vomiting (n) 3 (10%) 7 (23.33%) P= 0.299
Sedation (n) 0 (0%) 1 (3.33%) P= 0.999
Pruritus (n) 0 (0%) 2 (6.66%) P= 0. 473
Data are expressed as number (percent %).
P< 0.05 is considered signiﬁcant. P> 0.05 is non-signiﬁcant.
394 M.S. Mahmoud et al.to conﬁrm our hypothesis and to study the effect of amino acid
volume load and ammonia production in parturient especially
those with hepatic or renal impairment.
Perioperative thermal discomfort is often remembered by
patients as the worst aspect of their perioperative experience
[31]. Prophylaxis of postoperative shivering with simplepharmacological interventions is possible and clinically effec-
tive if the risk of developing postoperative shivering is high.
A novel approach to marinating perioperative normother-
mia has recently been proposed. An intravenous infusion of
an amino acid mixture commenced before and continued dur-
ing anesthesia was found to stimulate metabolic heat produc-
tion ﬁvefold compared with the thermogenic effect of amino
acids observed in the unanesthetized state. This thermogenesis
was associated with an increased body temperature [32] which
originated predominantly from the extra-splanchnic circula-
tion [8]. However, the increased temperature was achieved
not only by increased non-shivering thermogenesis but also
by vasoconstriction, reduced cutaneous heat loss [32,33].
Amino acids thus inﬂuence both peripheral and heat pro-
duction and central thermoregulatory control. Synchronous
increase in each of the major autonomic thermoregulatory
thresholds suggests an alteration in central thermoregulatory
function rather than the summation of individual peripheral
actions related to each thermoregulatory defense. The mecha-
nism by which amino acid infusion increases the set point was
Table 6 Neonatal outcomes.
Variable Group A
(n= 30)
Group M
(n= 30)
P-value
Weight (g)a 3186 ± 376 3287 ± 425 P= 0.334
1-min Apgarb 9 (8–9) 9 (8–9) P= 0.94
5-min Apgarb 9 (9–9) 9 (9–9) –
Umbilical arterya
pH 7.22 ± 0.13 7. 19 ± 0.09 P= 0.303
PO2 16.97 ± 5.5 18.26 ± 5.2 P= 0.354
PCO2 52.8 ± 4.6 54.2 ± 5. 1 P= 0.269
HCO3 23.5 ± 1.9 24.3 ± 1.7 P= 0.091
Admission to NICU (n)c 0 (0%) 0 (0%) NA
Lactationc diﬃculties 2 (6.66%) 1 (3.33%) P= 0.9995
P> 0.05 is considered non-signiﬁcant.
Data are expressed as
a Mean ± SD.
b Median and (range).
c Number (percent %).
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peripherally infused amino acids are unlikely to cross the
blood brain barrier. It is therefore unlikely that amino acids
directly alter central thermoregulatory control. One potential
mediator is the sympathetic nervous system. However, intra-
venous administration of amino acids solutions to patients
causes a normal or even supra normal increase in metabolic
rate even though pathway connecting the brain with the
peripheral sympathetic nerve pathways to the brain is served
in these patients and they typically exhibit low peripheral
sympathetic system activity [34].
Meperidine (pethidine) is one of the opioids which is
remarkably effective in treating postoperative shivering
(25 mg) whether given intravenously or intrathecally [34–36]
and is unlikely to induce clinically relevant adverse effects in
this low dose.
Roy et al. [37] found that adding pethidine intrathecally
does not modify the efﬁcacy of the sensory and motor block
or its maximum spread but they reported that pethidine
0.2 mg/kg intrathecally lowers the incidence of shivering dur-
ing spinal anesthesia.
Hong and Lee [38] reported that 10 mg of prophylactic
intrathecal pethidine for cesarean delivery reduced the
incidence and severity of shivering much more than 0.2 mg
morphine intrathecally.
Nakajima et al. [39] reported that amino acid intravenous
infusion increased both metabolic rate and resting core
temperature during anesthesia. They contributed this to that
it produced a synchronous increase in all major autonomic
thermoregulatory defense thresholds.
As a limitation to the study we did not consider the
hormonal effect on shivering in pregnant women. Pregnant
women have very high circulating concentrations of
progesterone. This may account for elevated thresholds [40].
We did not measure progesterone levels in our patients.
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